Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

With this project, the study group wants to investigate whether a postoperative navigated transcranial magnetic stimulation (nTMS) motor map can improve stereotactic radiosurgery (SRS) planning in patients who underwent resection for a brain metastasis near the primary motor cortex. Specifically, the map could allow for more precise location of motor eloquent tissue, thereby minimizing the radiation dose on these areas while preserving high radiation dose on target tissue (i.e. tumor cells).

Eligibility criteria

Qualifiers

Informed consent

Age ≥ 18 years

Cerebral metastasis within or adjacent to the primary motor cortex (≤10 mm)

Resection of tumor

Disqualifiers

Contraindication to TMS (e.g. Cochlear Implant, other metallic or electrical implants, excluding teeth and post craniotomy, Meniere's disease, pacemaker, deep brain stimulation electrodes, refractory convulsion, symptomatic tinnitus, depression diagnosed by a specialist, psychosis)

Prior cerebral radiation therapy within the affected precentral gyrus/affecting the planned SRS plan

Planned whole brain radiotherapy

Second lesion within 2 cm ipsilateral in the primary motor cortex

Trial design

Treatments tested in this trial

  • Navigated Transcranial Magnetic Stimulation (nTMS)

Treatment groups

30 Participants
are divided into 1 treatment group